Literature DB >> 2435060

Epitopes on foot-and-mouth disease virus particles. I. Topology.

K C McCullough, J R Crowther, W C Carpenter, E Brocchi, L Capucci, F De Simone, Q Xie, D McCahon.   

Abstract

Monoclonal antibodies (MAb) against an O1 Suisse isolate of FMDV were used to identify epitopes on the virus particle and to determine their relative function. Six major antigenic sites containing one or more epitopes were identified using competition ELISA. An epitope relationship is proposed consisting of a trypsin-sensitive sequential site, termed B2/D9, from the codings for the MAb which reacted with it, which was associated with virus infectivity and is probably at or near to the cell-binding site of the virion; a trypsin-resistant, conformational site 1C6/4C9 MAb reaction at which also resulted in neutralization of virus infectivity; a second trypsin-resistant, conformational site 3C8, where again MAb reaction neutralised virus infectivity; a third trypsin-resistant, conformational site 6C3/2G5, at which MAb-dependent neutralisation of virus infectivity was inefficient; a site 3G4, the expression of which was impaired but not destroyed by trypsin treatment, and was not related to virus infectivity; an internal site A8, which appears to be a "12S subunit-specific" site. This work clearly demonstrates for the first time that both trypsin-sensitive and trypsin-resistant neutralisable (infectivity-associated) sites exist on the FMDV particle, and only one of these can be related to the sequential site used to formulate current FMDV peptide vaccines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435060     DOI: 10.1016/0042-6822(87)90294-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

Authors:  J R Crowther; C A Rowe; R Butcher
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

Review 3.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

4.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 5.  Monoclonal antibodies: implications for virology. Brief review.

Authors:  K C McCullough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

Authors:  K C McCullough; D Parkinson; J R Crowther
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

7.  Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.

Authors:  J D Kitson; K L Burke; L A Pullen; G J Belsham; J W Almond
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Epitopes functional in neutralization of varicella-zoster virus.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

Review 9.  Protective immune response against foot-and-mouth disease.

Authors:  K C McCullough; F De Simone; E Brocchi; L Capucci; J R Crowther; U Kihm
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers.

Authors:  Rachael C Rigden; Carlos P Carrasco; Artur Summerfield; Kenneth C MCCullough
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.